Advertisement

Topics

Biotechnology - Biotech Research

08:15 EST 24th November 2017 | BioPortfolio

Re-Framing Biotechnology Regulation.

Biotechnology is about to spill the banks of federal regulation. New genetic engineering techniques like CRISPR-Cas9 promise revolutionary breakthroughs in medicine, agriculture, and public health—but those techniques would not be regulated under the terms of the Coordinated Framework for Regulation of Biotechnology. This revolutionary moment in biotechnology offers an opportunity to correct the...

Biotechnology: A highly efficient tool for the current environmental challenges.

AFOB Special Issue on Industrial Biotechnology.

Third-quarter biotech job picture.

Around the world in a month.

Allergan's Mohawk evergreening patent deal draws criticism, but ultimately may flop.

RET-oncogene-targeting drugs draw notice.

Recent patents related to germline modification.

First AAV gene therapy poised for landmark approval.

3Q17-Funding and partnership into overdrive.

Spanish group defeats Shkreli in Chagas voucher race.

Reproducing with DNA.

When replacement becomes reversion.

Duchenne drug clings on for FDA nod.

First rounders: Stelios Papadopoulos.

Revisiting the Warnock rule.

Public views on gene editing and its uses.

Corrections.

This corrects the article DOI: 10.1038/nbt0617-493.

Ethical principles for the use of human cellular biotechnologies.

Query the merits of embryo editing for reproductive research now.

Humans 2.0.

Age-related macular degeneration foils drugmakers.

With Alnylam's amyloidosis success, RNAi approval hopes soar.

Coiled coils unspring protein origami.

Better beings?

Quick Search
Advertisement
 

review and buy Biotechnology - Biotech market research data and corporate reports here